Gatifloxacin mesylate
CAS No. 316819-28-0
Gatifloxacin mesylate ( AM 1155 mesylate;BMS 206584-01 mesylate;PD 135432 mesylate )
产品货号. M14034 CAS No. 316819-28-0
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥405 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Gatifloxacin mesylate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
-
产品描述A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV; displays 2- to 16-fold more active than ciprofloxacin and ofloxacin against Staphylococcus aureus with MICs of 0.1-0.78 ug/mL.
-
同义词AM 1155 mesylate;BMS 206584-01 mesylate;PD 135432 mesylate
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number316819-28-0
-
分子量471.50
-
分子式C20H26FN3O7S
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESCC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.CS(=O)(=O)O
-
化学全称3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-,methanesulfonate(1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hosaka M, et al. Antimicrob Agents Chemother. 1992 Oct;36(10):2108-17.
2. Tomioka H, et al. Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63.
3. Wakabayashi E, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):594-601.
2. Tomioka H, et al. Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63.
3. Wakabayashi E, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):594-601.
产品手册
关联产品
-
Maduramycin Ammonium
Maduramycin Ammonium is an anticoccidial agent for the the treatment of Eimeria spp. E. adenoeides E. gallopavonis and E. dispersa infection.
-
Sortase-IN-6e
A small molecule inhibitor of Staphylococcus aureus sortase with IC50 of 9.3 uM.
-
FSL 1
TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.